Skip to main content
. Author manuscript; available in PMC: 2018 Sep 15.
Published in final edited form as: Cancer Res. 2017 Jul 20;77(18):5026–5038. doi: 10.1158/0008-5472.CAN-16-2834

Table 1. Tricarbonic acid cycle and glycolysis metabolite level alteration in Nf2-deficient cells.

Levels of metabolites as measured by gas chromatography and high performance liquid chromatography. Bolded, underlined numbers indicate significant differences (p ≤ 0.05) between the groups shown, metabolite ratio of <1.00. Greyed, underlined boxes indicate significant difference (p ≤ 0.05) between the groups shown; metabolite ratio of ≥ 1.00. Two-tailed Welch’s t-test was used to compare FH912 and FC912 cells, n = 5. Two-way ANOVA contrasts were used to compare Nf2−/− and Nf2f/f MEFs and to evaluate cerulenin treatment effects.

Super Pathway Sub Pathway Biochemical Name Fold change
Two-Way ANOVA Contrasts Welch’s Two-Sample t-Test
MEFNf2-/-MEFNf2f/f
FH912FC912
Energy TCA Cycle citrate 1.47 0.45
succinate 2.62 1.56
fumarate 1.23 0.47
malate 1.94 0.33
Oxidative Phosphorylation acetylphosphate 1.8 0.45
pyrophosphate 0.81 0.78
phosphate 1.01 0.74
Glycolysis, Gluconeogenesis, and Pyruvate Metabolism glucose 0.32 1.45
glucose-6-phosphate 0.74 0.05
glucose 1-phosphate 1.12 0.68
fructose-6-phosphate 0.82 0.16
3-phosphoglycerate 0.12 0.52
pyruvate 0.56 1.59
lactate 1.13 1.1
glycerate 0.35 0.89
HHS Vulnerability Disclosure